Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion ...
Every time Henry publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Abstract: This manuscript investigates a sigma-delta–based cycle-skipping modulation strategy for power regulation and current sharing in modular series resonant DC transformers. The method enables ...
Treatment with the experimental oral therapy GRI-0621 modulated immune cell activity in adults with idiopathic pulmonary fibrosis (IPF) in an early Phase 2a clinical trial, according to new data ...
A new technical paper titled “Hybrid tungsten oxyselenide/graphene electrodes for near-lossless 2D semiconductor phase modulators” was published by researchers at Nanyang Technological University, ...
Treatment of chronic lymphocytic leukemia (CLL) currently consists of two main approaches — continuous therapy with Bruton’s tyrosine kinase inhibitors and fixed-duration regimens combining venetoclax ...
On Friday, Dec. 5, an immersive art installation mixing traditional painting and photography with digital animations, artificial intelligence, music and augmented reality will open at The Lab at ...
Novo Nordisk is hitting the gas on amycretin development. After posting phase 2 data, the company has decided to run pivotal diabetes trials of an asset that it previously saw primarily as an obesity ...
Forbes contributors publish independent expert analyses and insights. Tony Bradley covers the intersection of tech and entertainment. For years, cybersecurity strategy has followed a familiar playbook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results